A Therapy for Baby Boomers to Sleep OnAugust 18, 2008If you're over 55 and have spent more than a few sleepless nights, you're not alone -- insomnia affects about half of all people over 55 ― but you may also be at increased risk for physical and mental ailments. Many older adults don't get enough restorative sleep, leading to serious health concerns, including cardiovascular disease, obesity, diabetes, memory problems and increased rates of depression. Unfortunately, current sleeping pills are associated with memory problems, a risk for falls, dependency, withdrawal symptoms and disturbed sleeping patterns. Circadin, a new drug developed at Tel Aviv University by Prof. Nava Zisapel, a chemist and neurobiologist from TAU's George S. Wise Faculty of Life Sciences, may help America's aging baby boomers get the much-needed sleep they need. Recent results from Prof. Zisapel's research with Circadin appear in the Journal of Sleep Research and are reviewed in Aging Health.
How the Body Tells Time Prof. Zisapel's research centers on the hormone melatonin, which affects the way our biological functions differentiate between day and night. "As we age, the melatonin hormone signal weakens," says Prof. Zisapel. "As a result, our bodies and brains feel less difference between day and night." Exacerbating the effect of low melatonin levels, aging people tend to sleep in a less organized fashion than younger people, Prof. Zisapel explains. "People are sleeping in front of the TV, or nodding off during conversations, and taking long afternoon naps. This leads to less sleep at night. In a way, their sleep habits become more like babies', and less like those of healthy adults who sleep in consolidated periods during the night." Mimicking the profile of nighttime melatonin found in our bodies, Circadin replenishes the much-needed hormone, which declines steadily with age. Clinical trials in the United States and Europe found that Circadin improves sleep quality and morning alertness, and helps those 55 and over get a better night's sleep. Her new drug therapy "improves sleep and daytime vigilance, helping to re-organize the circadian system, the body's internal clock," Prof. Zisapel says. Added benefits include more normalized blood pressure and blood sugar levels at night. The formulation also has a profound effect on the blind, whose biological clock is disturbed because they can't see light, a trigger for synchronizing with the external day/night cycle. Advice for Sound Sleep Hygiene Until Circadin is available in the United States, there are some simple steps seniors can take to get a good night's sleep, Prof. Zisapel says. Spending a couple of hours outdoors every day can help. Sipping lattes on a cafe patio (away from direct sunlight) can be pleasurable, and increases the exposure to natural light from the blue-green spectrum. Experiencing a full spectrum of light during the day could also be beneficial, as is routine exercise and avoiding daytime naps and sleeping in front of the TV. Prof. Zisapel is the past director of the Adams Brain Research Center at Tel Aviv University and is the Chief Scientific Officer of Neurim Pharmaceuticals, a company commercializing the technology and licensing it from Ramot, the technology transfer arm of Tel Aviv University. The new drug is currently available in Europe, and is expected to be in the United States by next year. American Friends of Tel Aviv University | |||||||||||||||||||||
|
Related Insomnia Current Events and Insomnia News Articles Study shows pine bark reduces jetlag A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent. Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults A study in the Nov. 1 issue of the journal Sleep is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia, providing greater insight to the limited understanding of the condition's pathology. VYVANSE provided behavior, inattention and math test score improvements in children with ADHD Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a 13-hour analog classroom study in school-aged children aged 6 to 12 years with Attention Deficit Hyperactivity Disorder (ADHD). New promising obesity drug may have huge potential According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. Respiratory rhythms can help predict insomnia The breathing and heart rates and cortisol levels of women with metastatic breast cancer can be used to predict if they'll suffer from chronic insomnia and sleep disruptions, a common complaint from patients who want to maintain their quality of life. Insomnia in women with breast cancer linked to heart rate dysregulation A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope. Learning to shape your brain activity A study in the Oct. 1 issue of the journal Sleep shows that the successful manipulation of sensorimotor rhythm (SMR) amplitude by instrumental SMR conditioning (ISC) improved sleep quality as well as declarative learning. ISC might thus be considered a promising non-pharmacological treatment for primary insomnia. Adolescent insomnia linked to depression and substance abuse during adolescence and young adulthood A study in the Oct. 1 issue of the journal Sleep shows that adolescent insomnia symptoms are associated with depression, suicide ideation and attempts, and the use of alcohol, cannabis and other drugs such as cocaine. Restless nights put older adults at risk for depression recurrence Nearly 60 percent of the nation's elderly have trouble sleeping, whether it's a lot of tossing and turning or outright bouts of insomnia. While for most people sleeplessness can be annoying at best or unhealthy at worst, for elderly individuals who have suffered from depression in the past, poor sleep may be the first sign that a new bout of depression is coming on. Researchers Investigate Impact of Stress on Police Officers' Physical and Mental Health Policing is dangerous work, and the danger lurks not on the streets alone. More Insomnia Current Events and Insomnia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||